Pharmability AB
PrivateLast Round
Early Funding
Apr 9, 2025
Total Funding Raised
$5.66M
Company Overview
Pharmability AB operates in Healthcare & Life Sciences and is based in Stockholm. Its latest recorded funding round was an Early Funding round in April 2025.
Pharmability AB is a biotechnology company developing next-generation immunomodulatory therapies for autoimmune skin diseases, with an initial focus on atopic dermatitis.
Sector
Healthcare & Life Sciences
Verticals
Compliance & Risk, Quality Management, Biotechnology, Clinical Trials, RegTech
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharmability AB Comparables
Compare Pharmability AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abrahamsson Pharma Consulting AB | 89% | |
| Scandinavian Regulatory Services AB | 88% | |
| RegSmart Life Science AB | 87% |
For institutional investors. Book with your work email.
Pharmability AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 9, 2025 | ||||
| Grant | Aug 1, 2024 | ||||
| Early Funding | Nov 20, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pharmability AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Almi Invest AB | Early Funding |
| Vinnova | Grant |
| Sciety | Early Funding |
| Swelife | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
Partnered with Bachem Americas, Inc. for atopic dermatitis therapy.
- Nov 6, 2025
Strengthening collaboration with Zelmic AB.
For institutional investors. Book with your work email.
Pharmability AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pharmability AB's valuation, stock price, and market status.
Is Pharmability AB a public or private company?
Pharmability AB is a private company.
What is the current stock price of Pharmability AB?
Pharmability AB is a private company, so its shares have no public market price. Caplight tracks Pharmability AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pharmability AB worth (valuation)?
Valuation information for Pharmability AB is not publicly available.
Can I buy Pharmability AB stock?
Pharmability AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pharmability AB's last funding round?
Pharmability AB's most recent funding round was Early Funding on April 9, 2025.
Who are the main investors in Pharmability AB?
Key investors in Pharmability AB include Sciety.
Will Pharmability AB IPO soon?
No public IPO plans have been announced for Pharmability AB.
How can I track Pharmability AB secondary market activity?
Caplight tracks bids, offers, and trades in Pharmability AB's shares on secondary markets.